ArticleJournal of Cancer2017

A Multi-Center Prospective Study to Validate an Algorithm Using Urine and Plasma Biomarkers for Predicting Gleason ≥3+4 Prostate Cancer on Biopsy.

Maher Albitar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.